Northway Biotech Capacity Update October 2024: Large Molecule Drug Substance

Explore Northway Biotech’s capabilities, competitive advantages, and current capacity to onboard new projects across its two facilities: Waltham, MA, operational since 2020, and Vilnius, Lithuania, established in 2004.

With over 20 years of expertise and more than 175 completed mammalian and microbial projects, Northway Biotech’s facilities are equipped with state-of-the-art technology and are strategically positioned for new client partnerships. As a one-stop shop for CDMO services, Northway Biotech supports clients through every phase — from cell line and process development to cGMP manufacturing of drug substances and drug products.